Performance and comparison of FLCCheck: a novel serum free light chain assay for the Auxiliary Diagnosis of Multiple Myeloma
Our findings show satisfactory consistency between the three FLC testing methods, but their interchangeability is not recommended. Consistent use of the same assay method across all reports is essential. The development of new FLC detection methods is valuable for optimizing disease monitoring, prognosis, and the management of multiple myeloma and related diseases.
Authors
- Yajuan Lu (ORCID: https://orcid.org/0000-0003-0132-2952)
- Jie Cao (ORCID: https://orcid.org/0000-0002-9293-6513)
- Jun Xia (ORCID: https://orcid.org/0000-0003-3222-2882)
- Xi Chen (ORCID: https://orcid.org/0000-0002-7995-6202)
- Yuhan Chen (ORCID: https://orcid.org/0000-0001-9170-7439)
- Jing Du (ORCID: https://orcid.org/0000-0003-1142-0433)
- Yu Zhou (ORCID: https://orcid.org/0000-0002-7993-7909)
- Sainan Li (ORCID: https://orcid.org/0000-0002-7058-7869)
- Alan Y. Deng (ORCID: https://orcid.org/0000-0002-7216-9599)
Institutions
- Zhejiang Provincial People's Hospital (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1186/s40001-025-02984-8
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province